ZA201600894B - Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium or a pharmaceutically acceptable salt thereof in the prevention and treatment of diabetes - Google Patents

Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium or a pharmaceutically acceptable salt thereof in the prevention and treatment of diabetes

Info

Publication number
ZA201600894B
ZA201600894B ZA2016/00894A ZA201600894A ZA201600894B ZA 201600894 B ZA201600894 B ZA 201600894B ZA 2016/00894 A ZA2016/00894 A ZA 2016/00894A ZA 201600894 A ZA201600894 A ZA 201600894A ZA 201600894 B ZA201600894 B ZA 201600894B
Authority
ZA
South Africa
Prior art keywords
dimethylpropan
aminium
diabetes
carboxy
prevention
Prior art date
Application number
ZA2016/00894A
Other languages
English (en)
Inventor
Ilga Misane
Ilmars Stonans
Elina Makarova
Edgars Liepins
Ivars Kalvins
Helena Cirule
Maija Dambrova
Original Assignee
Grindeks Jsc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grindeks Jsc filed Critical Grindeks Jsc
Publication of ZA201600894B publication Critical patent/ZA201600894B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA2016/00894A 2013-09-26 2016-02-09 Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium or a pharmaceutically acceptable salt thereof in the prevention and treatment of diabetes ZA201600894B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13186201 2013-09-26
PCT/IB2014/064514 WO2015044828A1 (fr) 2013-09-26 2014-09-15 Utilisation de 3-carboxy-n-éthyl-n,n-diméthylpropan-1-aminium ou d'un sel pharmaceutiquement acceptable de celui-ci dans la prévention et le traitement du diabète

Publications (1)

Publication Number Publication Date
ZA201600894B true ZA201600894B (en) 2017-05-31

Family

ID=49231372

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2016/00894A ZA201600894B (en) 2013-09-26 2016-02-09 Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium or a pharmaceutically acceptable salt thereof in the prevention and treatment of diabetes

Country Status (9)

Country Link
CN (1) CN105530929B (fr)
AR (1) AR099638A1 (fr)
BR (1) BR112016004211B1 (fr)
CA (1) CA2924682C (fr)
JO (1) JO3333B1 (fr)
MX (1) MX368505B (fr)
TN (1) TN2016000064A1 (fr)
WO (1) WO2015044828A1 (fr)
ZA (1) ZA201600894B (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2067474A1 (fr) * 2007-12-05 2009-06-10 Grindeks, a joint stock company Nouvelle utilisation médicale de sel propionate 3-(2,2,2-trimethylhydrazinium)
LV14345B (lv) * 2009-10-22 2011-07-20 Grindeks, A/S 4-[Etil(dimetil)amonija]butanoāts un tā izmantošana kardiovaskulāro slimību ārstēšanai
BR112013027065B1 (pt) * 2011-04-27 2019-12-03 Grindeks Jsc processo para a preparação de sais de 3-carboxi-n-etil-n,n-dimetilpropan-1amínio, compostos e seus usos

Also Published As

Publication number Publication date
CA2924682C (fr) 2018-02-27
MX368505B (es) 2019-10-04
CN105530929A (zh) 2016-04-27
WO2015044828A1 (fr) 2015-04-02
JO3333B1 (ar) 2019-03-13
AR099638A1 (es) 2016-08-10
BR112016004211B1 (pt) 2022-09-06
CN105530929B (zh) 2018-03-02
CA2924682A1 (fr) 2015-04-02
BR112016004211A2 (fr) 2017-08-01
TN2016000064A1 (en) 2017-07-05
MX2016003347A (es) 2016-06-24

Similar Documents

Publication Publication Date Title
IL242610A0 (en) History of pyrazolopyrrolidine and their use in the treatment of diseases
IL239656A0 (en) Pyrimidone history and its use for the treatment, amelioration or prevention of viral disease
IL254142B (en) Tredifitant for use in the treatment of a disease or medical condition that responds to Tredifitent
PL3004112T3 (pl) Pochodne pirazolo-pirolidyn-4-onu oraz ich zastosowanie w leczeniu choroby
ZA201508050B (en) Use of landiolol hydrochloride in the long-term treatment of tachyarrhythmias
LT3057589T (lt) (s)-pirlindolas ir jo farmaciniu požiūriu priimtinos druskos, skirti naudoti medicinoje
ZA201607581B (en) Dosage forms and therapeutic uses l-4lchlorokynurenine
IL244693A0 (en) History of piperazine and their use as drugs
EP3065548A4 (fr) Composés inhibiteurs de fibrose et leurs méthodes d'utilisation pour prévenir ou traiter les maladies fibrotiques
GB2510477B (en) Formulations for use in the treatment of chronic fatigue and associated conditions, etc
SI2699545T1 (sl) Novi amino-pirolinski derivati in uporaba le-teh pri preprečevanju in/ali zdravljenju metaboličnega sindroma
ZA201600894B (en) Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium or a pharmaceutically acceptable salt thereof in the prevention and treatment of diabetes
AP2015008726A0 (en) Low-glycerin-formulations for hiv treatment and prevention
ZA201505093B (en) Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium or a pharmaceutically acceptable salt thereof in the treatment of atherosclerosis
IL251930A0 (en) Anylhydroxy derivatives, their preparation and medical uses
GB201312129D0 (en) Drug combination and its use in therapy
GB201312131D0 (en) Drug combination and its use in therapy
GB201312128D0 (en) Drug combination and its use in therapy
AP2015008849A0 (en) Pyrazolopyrrolidine derivatives and their use in the treatment of disease